Navigation Links
Economic Growth To Continue Throughout 2013
Date:4/30/2013

ate, Rental & Leasing; Mining; Accommodation & Food Services; Professional, Scientific & Technical Services; Arts, Entertainment & Recreation; Finance & Insurance; Educational Services; Utilities; Retail Trade; Transportation & Warehousing; Health Care & Social Assistance; and Information.Prices – Predicted Changes Between End of 2012 and End of 2013ManufacturingNon-ManufacturingPredicted

Dec 2012

Predicted

April 2013

Magnitude

of Change

Predicted

Dec 2012

Predicted

April 2013

Magnitude

of ChangeHigher

63%

55%

+5.6%

71%

60%

+4.7%Same

22%

28%

NA

18%

33%

NALower

15%

17%

-4.6%

11%

7%

-6.0%Net Average

+2.8%+2.3%

+2.7%+2.4%EMPLOYMENTChange in Overall Employment – Balance 2013Manufacturing
ISM's Manufacturing Business Survey respondents forecast that manufacturing employment will increase 0.9 percent during the balance of 2013, with 32 percent expecting employment to be 6.1 percent higher. This is in contrast to the 17 percent who predict employment to be lower by 6.2 percent. The remaining 51 percent of respondents expect their employment levels to be unchanged for the remainder of 2013. The 10 industries reporting expectations of growth in employment during the year — listed in order — are: Furniture & Related Products; Wood Products; Electrical Equipment, Appliances & Components; Fabricated Metal Products; Printing & Related Support Activities; Paper Products; Plastics & Rubber Products; Miscellaneous Manufacturing; Transportation Equipment; and Machinery.

Non-Manufacturing
ISM's Non-Manufacturing Business Survey Committee respondents forecast that employment will increase 1.3 percent during the balance of 2013. For the
'/>"/>

SOURCE Institute for Supply Management
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology news :

1. U.S. Army and Vermillion to Assess Health and Economic Benefits of OVA1 as a Standard of Care
2. NRELs economic benefit to Colorado totals $814.8 million in FY 2012
3. New whole plant therapy shows promise as an effective and economical treatment for malaria
4. New health-economic model shows benefits of boosting dietary calcium intake
5. Texas Biomed reports faster, more economical method for detecting bioterror threats
6. Global economic pressures trickle down to local landscape change, altering disease risk
7. Molecular economics: New computer models calculate systems-wide costs of gene expression
8. Study shows economic feasibility for capturing carbon dioxide directly from the air
9. An economical, effective and biocompatible gene therapy strategy promotes cardiac repair
10. Scientific meeting at Virginia Tech will make more than $2 million economic impact
11. Socioeconomics may affect toddlers exposure to flame retardants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2015)... May 18, 2015 Fingerprint Cards (FPC) ... FPC1025, FPC1145, FPC1155 and FPC1035 from one if its module ... and including Q3 2015 and the sensors will be used ... order values for 2015 hereby amount to 740 MSEK to ... of 140 MSEK and a number of smaller orders not ...
(Date:5/14/2015)... , May 14, 2015  Verificient ... identity verification and online remote proctoring, announced ... software-as-a-service (SaaS) company and creator of the ... of the two companies will benefit from ... Canvas. As a fully integrated ...
(Date:5/8/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), the ... of the executive management team will present at the following ... and Telecom Conference Date: May 18, 2015 Time: ... MA Cowen and Company Technology, Media ... Location: The New York Palace Hotel, New York, ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Synaptics to Present at Upcoming Investor Conferences 2
... Society applauds the Government of Argentina for creating two ... with majestic shorelines and abundant wildlife. The new ... Marine Parkwere recently established by the National Congress in ... other marine and coastal species., "We commend the Government ...
... This press release is available in German . ... of human infants was investigated using the prominent ,Stanford Marshmallow Experiment,: ... could either eat it now or wait and receive a second ... delay of several minutes. Interestingly, children that were able to wait ...
... study published online today in Nature Communications , researchers ... Sciences, BGI-Shenzhen, and University of Arizona have completed the genome ... provides new insights for researchers to understand the function and ... Oryza is an idea model system for studying plant ...
Cached Biology News:2 new marine protected areas created on Argentina's southern coasts 22 new marine protected areas created on Argentina's southern coasts 3Doing business with a parrot 2Whole genome sequencing of wild rice reveals the mechanisms underlying oryza genome evolution 2
(Date:5/22/2015)... 22, 2015 Knowledgent , the ... that explores the potential of big data analytics in ... was developed to help life sciences and healthcare organizations ... to gain critical business insights. , The life sciences ... data driven by patient profiling, compliance and regulatory requirements, ...
(Date:5/21/2015)... /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") ... and commercializes proprietary technologies and products for advanced microarray ... the second fiscal quarter ended March 31, 2015. ... advance business with our existing customers and to develop ... CEO of SQI. "The delivery of a fully automated ...
(Date:5/21/2015)... Specialty Pharmacy Times has completed ... to BPA Worldwide as a business publication member. ... data for Specialty Pharmacy Times based on business/distribution, ... a member of BPA Worldwide, Specialty Pharmacy Times ... with the most reliable, unequaled data,” said Chris ...
(Date:5/21/2015)... -- Prima Biomed Ltd. (NASDAQ: PBMD ) a globally ... leader in the development of immunotherapeutic products for the ... data from the Phase II CAN-003 ovarian cancer clinical ... meaningful improvement in Overall Survival ("OS") over standard of ... the group of second remission patients (n=20), the median ...
Breaking Biology Technology:New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8Specialty Pharmacy Times Joins BPA Worldwide 2Correction Continues after Big Move - BrokerBank Securities, Inc. 2
... Even HealthierST. LOUIS, March 31 Recent research reveals ... be beneficial to the diet. And, the majority recognizes ... such as soyfoods even healthier. These findings come from ... - sponsored by the United Soybean Board (USB) ...
... Shire plc (LSE: SHP,NASDAQ: SHPGY ), ... agreement with GlaxoSmithKline plc (NYSE: GSK ... aim of,improving recognition and treatment of ADHD in ... and will more than double the reach and,frequency ...
... U.S. FDA approves Intercell,s first marketed product, a new ... - Commercial product launch in the U.S. planned for ... today announced that the U.S. Food and Drug Administration ... of Japanese Encephalitis (JE). The initial target for use ...
Cached Biology Technology:Nearly 70 Percent of Health Professionals Support Biotechnology's Use in Food Products 2Nearly 70 Percent of Health Professionals Support Biotechnology's Use in Food Products 3Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD 2Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD 3Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD 4Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD 5Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD 6Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis 2Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis 3Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis 4